Ketki FlanneryAssociate Director MSAT and CMC at Autolous TherapeuticsSpeaker
Profile
With over 15 years of experience in cell and gene therapy, I specialize in CAR-T process development, GMP manufacturing, and regulatory CMC.
My career reflects a focus on immuno-oncology research and the development of cell and gene therapies that aim to improve patient outcomes. Dedicated to driving progress in oncology treatments, I collaborate with multidisciplinary teams to develop scalable and compliant manufacturing processes aligned with regulatory standards.
Agenda Sessions
Commercialisation of Cell Therapies: Cell Therapy Manufacturing Scale Up from Clinical to Commercial
, 11:45View Session
